New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors

International Journal of Molecular Sciences
Laura BoussetCyrille de Joussineau

Abstract

Prostate cancer (PCa) incidence has been dramatically increasing these last years in westernized countries. Though localized PCa is usually treated by radical prostatectomy, androgen deprivation therapy is preferred in locally advanced disease in combination with chemotherapy. Unfortunately, PCa goes into a castration-resistant state in the vast majority of the cases, leading to questions about the molecular mechanisms involving the steroids and their respective nuclear receptors in this relapse. Interestingly, liver X receptors (LXRα/NR1H3 and LXRβ/NR1H2) have emerged as new actors in prostate physiology, beyond their historical roles of cholesterol sensors. More importantly LXRs have been proposed to be good pharmacological targets in PCa. This rational has been based on numerous experiments performed in PCa cell lines and genetic animal models pointing out that using selective liver X receptor modulators (SLiMs) could actually be a good complementary therapy in patients with a castration resistant PCa. Hence, this review is focused on the interaction among the androgen receptors (AR/NR3C4), estrogen receptors (ERα/NR3A1 and ERβ/NR3A2), and LXRs in prostate homeostasis and their putative pharmacological modulations in paralle...Continue Reading

References

Nov 30, 1990·The Journal of Steroid Biochemistry and Molecular Biology·S E AbdelgadirJ A Resko
May 1, 1994·The Journal of Urology·M J SiegsmundI Pastan
Jan 1, 1993·Virchows Archiv. A, Pathological Anatomy and Histopathology·H Bonkhoff, K Remberger
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·H MiyamotoC Chang
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·B A JanowskiD J Mangelsdorf
Apr 23, 1999·The Journal of Biological Chemistry·W LuW L McKeehan
Aug 6, 1999·The American Journal of Pathology·H BonkhoffK Remberger
Jun 3, 2000·Human Pathology·L BubendorfM J Mihatsch
Dec 7, 2000·Journal of the National Cancer Institute·S SignorettiM Loda
Mar 10, 2001·The Journal of Endocrinology·M RoyuelaR Paniagua
Aug 25, 2001·Cancer Causes & Control : CCC·D S MichaudE Giovannucci
Jan 25, 2002·Annals of the New York Academy of Sciences·W C Song
Feb 22, 2002·International Journal of Cancer. Journal International Du Cancer·Johannes V SwinnenGuido Verhoeven
Aug 7, 2002·The Journal of Steroid Biochemistry and Molecular Biology·P R Kramer, S Wray
Sep 28, 2002·Molecular Endocrinology·Cynthia A Heinlein, Chawnshang Chang
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Shuyuan YehMin-Chi Hung
Oct 11, 2002·Nature·Sooryanarayana VaramballyArul M Chinnaiyan
Jan 14, 2003·Nature Medicine·Sean B JosephPeter Tontonoz
Jan 17, 2003·Molecular Biology of the Cell·Lyne LabrecqueRichard Béliveau
Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers
Feb 5, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James L MohlerFrank S French
May 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Stuart J EllemGail P Risbridger
Jun 3, 2004·Journal of the National Cancer Institute·Fred SaadUNKNOWN Zoledronic Acid Prostate Cancer Study Group
Jun 10, 2004·Proceedings of the National Academy of Sciences of the United States of America·Otabek ImamovJan-Ake Gustafsson
Oct 21, 2004·Cancer·David G BostwickBarry Timms
Jan 7, 2005·Seminars in Reproductive Medicine·Fernand Labrie
Jan 25, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Pirkko L Härkönen, Sari I Mäkelä
Mar 1, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K P WeinfurtK A Schulman
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew R SmithCelestia S Higano
Oct 18, 2005·BJU International·Nima SharifiJames L Gulley

❮ Previous
Next ❯

Citations

Jun 20, 2019·Cells·Masaki ShiotaMasatoshi Eto
May 28, 2020·International Journal of Molecular Sciences·Bagora BayalaJean-Marc A Lobaccaro
Dec 24, 2019·Cancer Control : Journal of the Moffitt Cancer Center·Fabio CofanoDiego Garbossa
Jul 6, 2021·Expert Opinion on Drug Discovery·Elisabete Nascimento-GonçalvesPaula A Oliveira

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation
ChIP-Seq
xenograft
sulfotransferase
transgenic

Clinical Trials Mentioned

NCT02922764

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Molecular and Cellular Endocrinology
Emilie ViennoisSilvère Baron
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Hielke J MeulenbeldRonald de Wit
© 2022 Meta ULC. All rights reserved